APP Abeta40, Human (Ponezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-APP Abeta40, Human (Ponezumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | APP Abeta40, Human (Ponezumab biosimilar) |
| Clone | Ponezumab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG2 kappa |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | ELISA, IP, FCM, FuncS, Neut |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human APP Abeta40 Recombinant Antibody. Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease. Ponezumab was developed by Pfizer Inc. In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial. Detailed reports have to be released. |
| Immunogen | n/a |
| Other Names | Anti-APP Abeta40 Recombinant Antibody, Research Grade Ponezumab, Anti-Human APP Abeta40 Recombinant Antibody, PF-04360365, RN-1219, clone 9TL, Antibody Drug Analogues, Monoclonal Antibody, YR1248, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 1178862-65-1 |
| Catalog # | YR1248 |
| Price | please inquire |
| Order / More Info | APP Abeta40, Human (Ponezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies